This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Articles

The Power Of Clinical Trial Supply Visibility

Over the last few years the number of innovative drugs brought to market has declined as pharmaceutical companies have focussed their resources on improvements to existing drugs or expanding their off-label use.

In part, the evolution of this trend can be traced to the advent of corporate mergers between pharmaceutical companies which has left much of the innovation gap in new medications to be filled by biopharma. Indeed, it is from these relatively small companies that the majority of new products and innovations have emerged in recent years…

Read more about this here

October 12, 2015


PCI Welcomes UK Government to US Center of Excellence and Headquarters

PCI Pharma Services welcomed an official visit by the UK Government to our US Headquarters in Philadelphia, Pennsylvania this week.... View Article

PCI Welcomes Laura Zurlinden to West Coast Sales Team

PCI Pharma Services is pleased to announce Laura Zurlinden has accepted the role of Director of Business Development – West... View Article

x